Cross SS - Search Results

1

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.

Yates DR, Rehman I, Meuth M, Cross SS, Hamdy FC, Catto JW. Yates DR, et al. Among authors: cross ss. Oncogene. 2006 Mar 23;25(13):1984-8. doi: 10.1038/sj.onc.1209209. Oncogene. 2006. PMID: 16288222

2

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.

Catto JW, Azzouzi AR, Amira N, Rehman I, Feeley KM, Cross SS, Fromont G, Sibony M, Hamdy FC, Cussenot O, Meuth M. Catto JW, et al. Among authors: cross ss. Oncogene. 2003 Nov 27;22(54):8699-706. doi: 10.1038/sj.onc.1206964. Oncogene. 2003. PMID: 14647464

3

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.

Rehman I, Cross SS, Azzouzi AR, Catto JW, Deloulme JC, Larre S, Champigneuille J, Fromont G, Cussenot O, Hamdy FC. Rehman I, et al. Among authors: cross ss. Br J Cancer. 2004 Aug 16;91(4):739-44. doi: 10.1038/sj.bjc.6602034. Br J Cancer. 2004. PMID: 15280928 Free PMC article.

4

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.

Rehman I, Azzouzi AR, Catto JW, Allen S, Cross SS, Feeley K, Meuth M, Hamdy FC. Rehman I, et al. Among authors: cross ss. Urology. 2004 Dec;64(6):1238-43. doi: 10.1016/j.urology.2004.06.063. Urology. 2004. PMID: 15596215

5

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.

Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC. Rehman I, et al. Among authors: cross ss. Hum Pathol. 2004 Nov;35(11):1385-91. doi: 10.1016/j.humpath.2004.07.015. Hum Pathol. 2004. PMID: 15668896

6

Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

Cross SS, Hamdy FC, Deloulme JC, Rehman I. Cross SS, et al. Histopathology. 2005 Mar;46(3):256-69. doi: 10.1111/j.1365-2559.2005.02097.x. Histopathology. 2005. PMID: 15720411

7

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.

Catto JW, Azzouzi AR, Rehman I, Feeley KM, Cross SS, Amira N, Fromont G, Sibony M, Cussenot O, Meuth M, Hamdy FC. Catto JW, et al. Among authors: cross ss. J Clin Oncol. 2005 May 1;23(13):2903-10. doi: 10.1200/JCO.2005.03.163. Epub 2005 Mar 7. J Clin Oncol. 2005. PMID: 15753461

8

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.

Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY, Hamdy FC. Rehman I, et al. Among authors: cross ss. Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302. Prostate. 2005. PMID: 16015609

9

Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.

Leiblich A, Cross SS, Catto JW, Phillips JT, Leung HY, Hamdy FC, Rehman I. Leiblich A, et al. Among authors: cross ss. Oncogene. 2006 May 11;25(20):2953-60. doi: 10.1038/sj.onc.1209262. Oncogene. 2006. PMID: 16547507

10

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.

Dhawan D, Hamdy FC, Rehman I, Patterson J, Cross SS, Feeley KM, Stephenson Y, Meuth M, Catto JW. Dhawan D, et al. Among authors: cross ss. J Pathol. 2006 Jul;209(3):336-43. doi: 10.1002/path.1991. J Pathol. 2006. PMID: 16639696

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters